Fresenius Medical Care Releases 2015 Annual Medical Quality Report
April 16 2015 - 8:30AM
Business Wire
Report Captures Company’s Focus on Treating
Patients with Renal and Other Chronic Illnesses
Fresenius Medical Care North America (FMCNA), a division of
Fresenius Medical Care (NYSE: FMS) and North America’s largest
provider of kidney care, hospitalist services and renal products,
announced today the release of its 2015 Annual Medical Quality
Report (AMQR).
The 2015 AMQR offers an overview of FMCNA’s coordinated care
efforts through its portfolio of core and new health business
assets, as well as clinical highlights leading up to 2015 across
the full spectrum of its health enterprise. This includes the
evolution of services and therapies that continue to improve the
health outcomes of patients with chronic care needs and reduce
costs to manage their care.
“Our efforts in 2015 focus on enhancing our ability to
coordinate health care in multiple venues, so patients with chronic
illness can receive the care they need where and when they need it
most,” said Dr. Frank Maddux, Chief Medical Officer of Fresenius
Medical Care North America. “By developing strong bonds between
patients and providers across the clinical care continuum, we can
improve patients’ lives and avoid consequences from their known
chronic illnesses. This year’s Annual Medical Quality Report
reflects what we have accomplished and what we are doing to achieve
our primary goal of improving the quality of life for patients
under our care.”
The 2015 Annual Medical Quality Report can be found on FMCNA’S
newly redesigned corporate website or download at:
www.freseniusmedicalcare.us/fileadmin/data/us/Media_Center/FMCNA-AMQR-2015.pdf.
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care
company focused on delivering the highest quality care to people
with renal and other chronic conditions. Through its
industry-leading network of dialysis facilities, outpatient cardiac
and vascular labs and urgent care centers, as well as the country’s
largest practice of hospitalist and post-acute providers, Fresenius
Medical Care provides coordinated health care services at pivotal
care points for hundreds of thousands of chronically ill customers
throughout the continent. As the world’s only vertically integrated
renal company, it offers specialty pharmacy and laboratory
services, and manufactures and distributes the most comprehensive
line of dialysis equipment, disposable products and renal
pharmaceuticals. For more information, visit the FMCNA website at
www.freseniusmedicalcare.us.
Media Contact:Fresenius Medical CareJon Stone, 781-699-9704(C)
781.392.4680Jonathan.d.stone@fmc-na.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Sep 2023 to Sep 2024